Literature DB >> 2598448

Platelet inhibition with an antibody to glycoprotein IIb/IIIa.

D J Fitzgerald1.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2598448     DOI： 10.1161/01.cir.80.6.1918

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  4 in total

Review 1.  Advances in thrombolytic therapy.

Authors:  M Verstraete
Journal:  Cardiovasc Drugs Ther       Date:  1992-04       Impact factor: 3.727

2.  Is thrombolysis alone the best therapy for acute myocardial infarction? Current status and emerging strategies.

Authors:  P Golino; J T Willerson
Journal:  Tex Heart Inst J       Date:  1991

3.  Effects of age, sex and the oral contraceptive on the platelet membrane fibrinogen binding site (glycoprotein IIb/IIIa).

Authors:  M Cahill; R Mistry; C Chapman; J K Wood; D B Barnett
Journal:  Br J Clin Pharmacol       Date:  1992-01       Impact factor: 4.335

4.  Platelet surface IgG in patients receiving infusions of Fab fragments of a chimaeric monoclonal antibody to glycoprotein IIb-IIIa.

Authors:  C Christopoulos
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.